Celiac disease or gluten intolerance is a common autoimmune disease with a genetic predisposition, with or without clinical symptoms. Over the last years, specific and sensitive tests have been developed for the diagnostic approach to this disease. The celiac disease exclusion package combines serological and molecular testing. In patients that follow a gluten free diet, serological diagnosis is not possible.

NON-INVASIVE TEST FOR THE EXCLUSION OF CELIAC DISEASE

• Tissue Transglutaminase Antibodies – IgA (a-tTG IgA)
• Deamidated Gliadin Peptide Antibodies – IgG (a-DGP IgG)
• HLA DQ8
• HLA DQ2

FULL CELIAC DISEASE DIAGNOSTIC TEST

• Tissue Transglutaminase Antibodies – IgA (a-tTG IgA)
• Tissue Transglutaminase Antibodies – IgG (a-tTG IgG)
• Deamidated Gliadin Peptide Antibodies – IgG (a-DGP IgG)
• Anti-Endomysial Antibodies – IgA (ΕmΑ)
• Deamidated Gliadin Peptide (DGP) Antibodies – IgA (a-DGP IgA)
• HLA-DQ8
• HLA-DQ2

CELIAC DISEASE PATIENT MONITORING

• Deamidated Gliadin Peptide Antibodies – IgG (a-DGP IgG)
• Tissue Transglutaminase Antibodies – IgA (a-tTG IgA)